InaVein Announces China Symposium

LEXINGTON, Mass. – April 30, 2009 -- InaVein, LLC announced today that it has organized a symposium to train physicians in China on the use of its TRIVEX System for removing extensive varicose veins. The TRIVEX China Symposium will be held at the China-Japan Friendship Hospital in Beijing on June 12th-13th, 2009. The Symposium will be hosted by Professor Lui Peng, Chairman of the Department of Vascular and Cardio-Thoracic Surgery in conjunction with the Union China National Medical Equipment Corp. (UCMC), InaVein’s corporate partner for the China market. Greg Spitz, M.D. (Aurora, IL USA) inventor of the TRIVEX System and technique will join Prof. Lui and his staff as faculty in training the vascular surgeons who are expected to attend from all over China.

About InaVein
InaVein, LLC is a privately held company engaged in the development, manufacture, marketing and commercialization of unique medical devices for the treatment of vein disease. The company’s flagship product, The TRIVEX™ System, is the first technology to provide surgeons with a minimally invasive technique to remove varicose veins safely and efficiently under direct vision. Since 2003, thousands of patients worldwide have been successfully treated using The TRIVEX System to completely remove their varicose veins. In addition, the company is developing other vascular products to assist clinicians in treating the full spectrum of conditions caused by peripheral venous disease.

For more information please contact:
InaVein
Michael McCartin
Vice President-Marketing and Sales
617.245.1965 ext. 1107